Top Markets
Coin of the day
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Rankning i aktier #13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Aktiekurs
$0.30840035
Marknadsvärde
$94.37M
Förändring (1 dag)
0.00%
Förändring (1 år)
-34.60%
Land
FR
Handel Sensorion SA (ALSEN)

Kategori

Historik för aktiesplit för Sensorion SA (ALSEN)
Aktien Sensorion SA (symbol: ALSEN) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Jul 13, 2026.
En ALSEN-aktie köpt före Jul 13, 2026 motsvarar nu 0 ALSEN-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
5 x199
DK
1 x2
US
0 -
US
0 -
BE
0 -
NL